PAION Deutschland GmbH, a wholly-owned subsidiary of PAION AG, is a biopharmaceutical company based in Aachen, Germany, aiming to become a leader in developing and commercialising innovative drugs for the treatment of stroke and other thrombotic diseases for which there is a substantial unmet medical need. Currently, PAION's activities are focused on the development of the three drugs Desmoteplase, Enecadin, and Solulin. During the first quarter 2005, PAION employed on average 56 people. Since 11 February 2005, PAION AG is listed at the Frankfurt Stock Exchange (Prime Standard Official Market, Stock Symbol PA8, ISIN DE000A0B65S3).
| Website | http://www.paion.de |
| Revenue | $12 million |
| Employees | View employees |
| Address | MARTINSTRASSE 10-12, Aachen, Nordrhein-Westfalen 52062, DE |
| Phone | +49 4924 14453 |
| Industry | Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
| Competitors | Hikma Pharmaceuticals, Gerresheimer, Baxter International Inc., Fresenius Group, Mylan Belgium, Teva Pharmaceuticals, IKARIA, Inc. - now a part of Mallinckrodt Pharmaceuticals., Sandoz, Accord Healthcare Greece, Amgen +46 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies |
Looking for a particular Paion Ag employee's phone or email?
Paion Ag Questions
The Paion Ag annual revenue was $12 million in 2026.
Paion Ag is based in Aachen, Nordrhein-Westfalen.
The NAICS codes for Paion Ag are [5417, 32541, 541, 3254, 32, 54, 325].
The SIC codes for Paion Ag are [283, 2834, 28].
